RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
Quell Therapeutics Ltd | Developer of engineered T regulatory cell therapies. | Series A | GBP 35,000,000 |
MOST ACTIVE INVESTORS
| Syncona Investment Management Ltd | 1 | |
| UCL Technology Fund | GB | 1 |
